Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Stock Forecast

Stock Price Forecast

According to 23 professional analysts, the 12-month price target for Sarepta Therapeutics stock ranges from a low of $10 to a high of $170. The average analyst price target of $64 forecasts a 274.05% increase in the stock price over the next year.

Price Target: $64.00 (+274.05%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$64	$50	$170
Change	-41.55%	+274.05%	+192.23%	+893.57%

Analyst Ratings

The average analyst rating for Sarepta Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	6	6	5	5	6	4
Buy	13	12	11	12	12	10
Hold	1	1	3	4	5	10
Sell	0	0	0	0	0	0
Strong Sell	2	2	2	1	0	1
Total	22	21	21	22	23	25

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Sell Downgrades $40 → $10	Hold → Strong Sell	Downgrades	$40 → $10	-41.55%	Jun 25, 2025
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains $123 → $45	Buy	Maintains	$123 → $45	+163.00%	Jun 20, 2025
Sami Corwin William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jun 20, 2025
Uy Ear Mizuho	Mizuho	Buy Maintains $85 → $40	Buy	Maintains	$85 → $40	+133.78%	Jun 18, 2025
David Hoang Deutsche Bank	Deutsche Bank	Hold Maintains $50 → $25	Hold	Maintains	$50 → $25	+46.11%	Jun 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.41B

Increased by 26.87%

from 1.90B

Revenue Next Year

2.49B

Increased by 3.15%

from 2.41B

EPS This Year

-2.57

from 2.34

EPS Next Year

4.70

from -2.57

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	540.10M	701.89M	933.01M	1.24B	1.90B	2.41B	2.49B	2.60B
Revenue Growth	41.82%	29.96%	32.93%	33.26%	52.97%	26.87%	3.15%	4.58%
EPS	-7.11	-5.15	-8.03	-5.80	2.34	-2.57	4.70	5.88
EPS Growth	-	-	-	-	-	-	-	25.25%
Forward PE	-	-	-	-	-	-	3.64	2.91
No. Analysts	-	-	-	-	-	29	28	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.0B	3.9B	4.0B
Avg	2.4B	2.5B	2.6B
Low	2.0B	1.1B	1.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	55.8%	63.2%	59.7%
Avg	26.9%	3.1%	4.6%
Low	2.6%	-52.7%	-47.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	0.98	14.18	15.27
Avg	-2.57	4.70	5.88
Low	-5.76	-2.12	-0.46

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-58.2%	-	225.1%
Avg	-	-	25.2%
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.